Ania Jastreboff, an endocrinologist and associate professor at the Yale School of Medicine, to discuss GLP-1 weight-loss medications and her own personal journey
Den Besten G, Bleeker A, Gerding A, Van Eunen K, Havinga R, Van Dijk TH, et al
Liraglutide (0.2 mg/kg) was intraperitoneally injected 45 min before performing insulin, glucose, and pyruvate tolerance tests (ITT, GTT and PTT respectively)
Planned Breaks: What the Evidence Shows Clinical data increasingly supports long-term semaglutide use rather than temporary treatment followed by discontinuation
Half-life ~6 days in human pharmacokinetic studies, supporting once-weekly dosing in trial protocols